Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present BioSyent Inc. (OTC: BIOYF).

Full DD Report for BIOYF

You must become a subscriber to view this report.


Recent News from (OTC: BIOYF)

BioSyent: Will This Canadian Success Story Continue?
The Business BioSyent is a Canadian specialty pharmaceutical company focused on sourcing, commercializing, and further develop niche pharmaceutical and healthcare products with peak sales of <$20 million that are not yet available in Canada but is commercialized in other countrie...
Source: SeekingAlpha
Date: March, 09 2018 09:50
BioSyent Inc. 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by BioSyent Inc. in conjunction with their 2017 Q3 earnings Read more ...
Source: SeekingAlpha
Date: November, 16 2017 22:26
BioSyent Inc. 2017 Q2 - Results - Earnings Call Slides
The following slide deck was published by BioSyent Inc. in conjunction with their 2017 Q2 earnings Read more ...
Source: SeekingAlpha
Date: August, 16 2017 14:07
BioSyent reports Q3 results
BioSyent ( OTCPK:BIOYF ): Q3 EPS of C$0.08. More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: November, 23 2016 08:06
BioSyent reports Q2 results
BioSyent ( OTCPK:BIOYF ): Q2 EPS of C$0.07 More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 12 2016 08:12
BioSyent reports Q1 results
BioSyent ( OTCPK:BIOYF ): Q1 EPS of C$0.07. More news on: BioSyent Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 27 2016 08:09
IIROC Trade Resumption - BioSyent Inc.
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2016) - Trading resumes in: IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issue...
Source: Newsfile
Date: May, 25 2016 13:00
IIROC Trade Halt - BioSyent Inc.
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2016) - The following issues have been halted by IIROC: IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the compa...
Source: Newsfile
Date: May, 25 2016 12:47
BioSyent Pharma Receives Health Canada Approval for New Urgent Care Product Using the Aguettant System(R)
TORONTO, ONTARIO--(Marketwired - May 5, 2016) - BioSyent Inc. ("BioSyent") (TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has received approval from Health Canada for a new urgent care product, phenylephrine hydrochloride injection in the...
Source: Marketwired
Date: May, 05 2016 08:00
BioSyent to Present at Upcoming Investor Conferences
TORONTO, ONTARIO--(Marketwired - April 6, 2016) - BioSyent Inc. ("BioSyent")(TSX VENTURE:RX)(OTC PINK:BIOYF) is pleased to announce that it will be presenting at the following upcoming investor conferences: April 7, 2016 - Laurentian Bank Securities Annual Institutional Investor Conferen...
Source: Marketwired
Date: April, 06 2016 14:07

 


About BioSyent Inc. (OTC: BIOYF)

Logo for BioSyent Inc. (OTC: BIOYF)

Not available

 

Contact Information

 

 

Current Management

  • Rene C. Goehrum / President, CEO
  • Rene C. Goehrum / Chairman

Current Share Structure

  • Market Cap: $99,218,000 - 03/16/2018
  • Issue and Outstanding: 13,300,000 - 06/06/2013

 



Daily Technical Chart for (OTC: BIOYF)

Daily Technical Chart for (OTC: BIOYF)


Stay tuned for daily updates and more on (OTC: BIOYF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BIOYF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIOYF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of BIOYF and does not buy, sell, or trade any shares of BIOYF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/